Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Serum triglyceride levels are not linked to prostate cancer risk.

No link found between hair loss severity and PSA levels in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Finasteride reduces bleeding during prostate surgery.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Certain natural compounds called terpenes may help prevent prostate cancer.

Four genes affect hair follicle density in goats.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Certain genetic markers may increase or decrease prostate cancer risk.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Obesity is linked to more severe lower urinary tract symptoms.